Patent · US Active

Biocatalysts for Ezetimibe synthesis

US10053673B2 · kind B2 · utility

2Cited by
35References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 4, 2017
Grant dateAug 21, 2018
Priority date—
Expiry dateApr 4, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12P17/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to non-naturally occurring polypeptides useful for preparing Ezetimibe, polynucleotides encoding the polypeptides, and methods of using the polypeptides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.